Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome

Clinical Neurology

Volumn 44, Issue 10, 2004, Pages 682-685

  Nakazato, Yoshihiko ^a   Ando, Satsuki ^a   Yamamoto, Toshimasa ^a   Tamura, Naotoshi ^a   Shimazu, Kunio ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Encephalopathy; Hyperammonemia; Sj gren's syndrome; Valproate

Indexed keywords

DIAZEPAM; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; BRAIN DISEASE; CASE REPORT; EPILEPSY; FEMALE; HUMAN; HYPERAMMONEMIA; LABORATORY TEST; RECURRENT DISEASE; SJOEGREN SYNDROME;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; HYPERAMMONEMIA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROTOXICITY SYNDROMES; SJOGREN'S SYNDROME; VALPROIC ACID;

EID: 9144253239     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Zaret BS, Beckner RR, Marini AM, et al : Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction. Neurology 1982 ; 32 : 206-208
2. Barrueto F, Hack JB : Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy. Acad Emerg Med 2001 ; 8 : 999-1001
3. Verrotti A, Trotta D, Morgese G, et al : Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002 ; 17 : 367-373
4. Kanae R, Kotagel S, Bacon BR, et al : Valproate use associated with persistent hyperammonemia and mitochondrial injury in a child with Down's syndrome. J Pediatr Gastroenterol Nutr 1992 ; 14 : 223-227
5. Ichikawa H, Amano T, Kawabata K, et al : Fatal hyperammonemia in a patient with systemic lupus erythematosus. Intern Med 1998 ; 37 : 700-703
6. Alexander EL, Provost TT, Stevens MB, et al : Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) 1982 ; 61 : 247-257